J 2021

Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia

BEZDĚKOVÁ, Renata, Tomas JELINEK, Romana KRÁLOVÁ, Martin ŠTORK, Petra POLACKOVA et. al.

Basic information

Original name

Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia

Authors

BEZDĚKOVÁ, Renata (203 Czech Republic, belonging to the institution), Tomas JELINEK (203 Czech Republic), Romana KRÁLOVÁ (203 Czech Republic, belonging to the institution), Martin ŠTORK (203 Czech Republic), Petra POLACKOVA (203 Czech Republic), Pavla VŠIANSKÁ (203 Czech Republic, belonging to the institution), Lucie KUBÍNOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Martina ALMÁŠI (203 Czech Republic, belonging to the institution), Ivanna BOICHUK (804 Ukraine), Zdenka KNECHTOVA (203 Czech Republic), Miroslav PENKA (203 Czech Republic), Luděk POUR (203 Czech Republic), Sabina ŠEVČÍKOVÁ (203 Czech Republic, belonging to the institution), Roman HAJEK (203 Czech Republic) and Lucie ŘÍHOVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

British journal of haematology, England, Wiley-Blackwell, 2021, 0007-1048

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30205 Hematology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 8.615

RIV identification code

RIV/00216224:14110/21:00122390

Organization unit

Faculty of Medicine

UT WoS

000694648500001

Keywords in English

plasma cell leukaemia; multiple myeloma; plasma cell; flow cytometry; prognosis; phenotype

Tags

International impact, Reviewed
Změněno: 7/12/2021 12:52, Mgr. Tereza Miškechová

Abstract

V originále

Plasma cell leukaemia (PCL) is a rare and very aggressive plasma cell disorder. Preventing a dismal outcome of PCL requires early diagnosis with appropriate analytical tools. Therefore, the investigation of 33 patients with primary and secondary PCL was done when the quantity of circulating plasma cells (PCs) using flow cytometry (FC) and morphology assessment was evaluated. The phenotypic profile of the PCs was also analysed to determine if there is an association with clinical outcomes and to evaluate the prognostic value of analysed markers. Our results revealed that FC is an excellent method for identifying circulating PCs as a significantly higher number was identified by FC than by morphology (26 center dot 7% vs. 13 center dot 5%, P = 0 center dot 02). None of secondary PCL cases expressed CD19 or CD20. A low level of expression with similar positivity of CD27, CD28, CD81 and CD117 was found in both PCL groups. A decrease of CD44 expression was detected only in secondary PCL. Expression of CD56 was present in more than half of PCL cases as well as cytoplasmic nestin. A decreased level of platelets, Eastern Cooperative Oncology Group score of 2-3 and lack of CD20(+) PC were associated with a higher risk of death. FC could be incorporated in PCL diagnostics not only to determine the number of circulating PCs, but also to assess their phenotype profile and this information should be useful in patients' diagnosis and possible prognosis.